跳至主要内容
临床试验/EUCTR2015-000955-25-FR
EUCTR2015-000955-25-FR进行中(未招募)1 期

Evaluation of the efficiency of folinic acid in children with autism spectrum disorders: a pilot study EFFET - EFFET

Centre Hospitalier Régional Universitaire de Nancy0 个研究点目标入组 40 人开始时间: 2015年6月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1)Children with autism spectrum disorders defined by : Autism Diagnostic Observation Schedule (ADOS), Autism Diagnostic Interview (ADI), Childhood Autism Rating Scale (CARS) or diagnosed by a physician (pediatrician, child psychiatrist)
  • 2)Children aged 3 to 10 years
  • 3)Weight> 10 kg
  • 4)Language impairment (based on the medical assessment)
  • 5)Ability to maintain other therapies started before the study
  • 6)No changes of therapeutic treatments within the 8 weeks before the start of the study
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 40
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1)Treatment may impair folate metabolism (methotrexate, anticonvuslivants : phenobarbital sodium valproate, phenytoin, primidone, carbamazepine, valproic acid, divalproex, antibiotics : tetracycline, trimethoprim, pyrimethamine, inhibitors of proton pump inhibitors of histamine-2)
  • 2)Antipsychotic treatment (including treatment with Risperidone)
  • 3)Vitamin or mineral supplementation exceeding guidelines
  • 4)Children with severe irritability (Aberrant Behavior Checklist> 17)
  • 5)Gastroesophageal reflux disease
  • 6)Any known renal or liver disease
  • 7)Child born premature (<37SA)
  • 8)Known intolerance to lactose
  • 9)Hypersensitivity / allergic reaction to calcium folinate
  • 10)The sibling children with autism spectrum disorders

研究者

发起方
Centre Hospitalier Régional Universitaire de Nancy

相似试验